Johnson
发表于 2025-3-21 18:07:44
书目名称Antiplatelet and Anticoagulation Therapy影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0158649<br><br> <br><br>书目名称Antiplatelet and Anticoagulation Therapy影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0158649<br><br> <br><br>书目名称Antiplatelet and Anticoagulation Therapy网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0158649<br><br> <br><br>书目名称Antiplatelet and Anticoagulation Therapy网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0158649<br><br> <br><br>书目名称Antiplatelet and Anticoagulation Therapy被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0158649<br><br> <br><br>书目名称Antiplatelet and Anticoagulation Therapy被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0158649<br><br> <br><br>书目名称Antiplatelet and Anticoagulation Therapy年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0158649<br><br> <br><br>书目名称Antiplatelet and Anticoagulation Therapy年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0158649<br><br> <br><br>书目名称Antiplatelet and Anticoagulation Therapy读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0158649<br><br> <br><br>书目名称Antiplatelet and Anticoagulation Therapy读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0158649<br><br> <br><br>
BARGE
发表于 2025-3-21 23:20:20
Antiplatelet Drug Resistance and Variability in Response: The Role of Antiplatelet Therapy Monitorieceptor blocker constitutes the mainstay of initial and long-term pharmacologic treatment during acute coronary syndrome and percutaneous coronary interventions. Clopidogrel, the most widely used P2Y12 receptor blocker, therapy is associated with numerous limitations- delayed onset of action, irreve
Supplement
发表于 2025-3-22 03:21:20
Anticoagulant Drugs: Current and Novel,sed in humans in 1937 and still enjoys widespread use today . During The Great Depression, financially strapped farmers in the Canadian prairies and Northern Plains of the United States were forced to feed their livestock moldy sweet clover hay resulting in the death from internal bleeding of pre
Cubicle
发表于 2025-3-22 08:07:12
Approaches to the Prophylaxis and Treatment of Venous and Cardiac Thromboembolic Disease,e vessel and its surroundings; (2) Phenomena due to blood coagulation; and (3) Phenomena due to the interruption of the blood stream . An updated description of these factors is: (1) Alteration in blood flow (i.e. stasis); (2) Vascular endothelial injury; and (3) Hypercoagulability. Clot formatio
恸哭
发表于 2025-3-22 10:28:50
2946-8183 tent approach to each topic in the series.Each volume is designed to be between 120 and 250 pages containing practical illustrations and designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas.978-1-4471-4296-6978-1-4471-4297-3Series ISSN 2946-8183 Series E-ISSN 2946-8191
装勇敢地做
发表于 2025-3-22 15:03:39
http://reply.papertrans.cn/16/1587/158649/158649_6.png
Glaci冰
发表于 2025-3-22 17:03:43
Surface Brillouin and Raman Scatteringr-weight heparin (LMWH) was introduced into widespread use in the mid 1990s. Since then, several new anticoagulants including argatroban, bivalirudin, lepirudin, fondaparinux, dabigatran, and rivaroxaban have become available, with numerous others likely to be marketed in the near future.
独裁政府
发表于 2025-3-22 22:58:39
Antiplatelet Agents: Current and Novel,table candidates for development. This chapter describes the pharmacology of those antiplatelet agents that a physician is likely to encounter in clinical practice both now and in the foreseeable future.
helper-T-cells
发表于 2025-3-23 02:39:33
http://reply.papertrans.cn/16/1587/158649/158649_9.png
执
发表于 2025-3-23 07:18:10
Book 2013-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose.The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series.Each volume is des